22nd April 2010
UK-NZ collaboration to home in on new anti-cancer drug for leukaemia
19th March 2010
CRT announces partnership with Cephalon to co-develop a new class of anti-cancer drugs
16th February 2010
Cancer Research UK and immatics biotechnologies to trial vaccine for brain cancer
7th February 2010
CRT and AstraZeneca form major alliance to create 'cancer metabolism' drugs
7th January 2010
Development deal for PKB inhibitor announced
4th January 2010
Deal struck for new investigational anti-cancer drug to target leukaemia and lymphoma
|